Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Hermeking

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Current Cancer Drug Targets|May 29, 2003
The MYC oncogene as a cancer drug targetHeiko Hermeking
Cancer Cell|November 13, 2007
p53 enters the microRNA worldHeiko Hermeking
Current Opinion in Oncology|December 20, 2002
Serial analysis of gene expression and cancerHeiko Hermeking
Nature Reviews. Cancer|August 18, 2012
MicroRNAs in the p53 network: micromanagement of tumour suppressionHeiko Hermeking
Advances in Experimental Medicine and Biology|August 31, 2016
Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal CancerMarkus Kaller, Heiko Hermeking
Cell Research|April 29, 2005
The role of epigenetic inactivation of 14-3-3sigma in human cancerDmitri Lodygin, Heiko Hermeking
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genesAntje Menssen, Heiko Hermeking
Oncotarget|July 10, 2015
p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3Sabine Hünten, Heiko Hermeking
Oncotarget|September 28, 2014
AP4 is required for mitogen- and c-MYC-induced cell cycle progressionRene Jackstadt, Heiko Hermeking
Cell Cycle (Georgetown, Tex.)|March 10, 2009
The c-MYC-AP4-p21 cascadePeter Jung, Heiko Hermeking
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Current Cancer Drug Targets|May 29, 2003
The MYC oncogene as a cancer drug targetHeiko Hermeking
Cancer Cell|November 13, 2007
p53 enters the microRNA worldHeiko Hermeking
Current Opinion in Oncology|December 20, 2002
Serial analysis of gene expression and cancerHeiko Hermeking
Nature Reviews. Cancer|August 18, 2012
MicroRNAs in the p53 network: micromanagement of tumour suppressionHeiko Hermeking
Advances in Experimental Medicine and Biology|August 31, 2016
Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal CancerMarkus Kaller, Heiko Hermeking
Cell Research|April 29, 2005
The role of epigenetic inactivation of 14-3-3sigma in human cancerDmitri Lodygin, Heiko Hermeking
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genesAntje Menssen, Heiko Hermeking
Oncotarget|July 10, 2015
p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3Sabine Hünten, Heiko Hermeking
Oncotarget|September 28, 2014
AP4 is required for mitogen- and c-MYC-induced cell cycle progressionRene Jackstadt, Heiko Hermeking
Cell Cycle (Georgetown, Tex.)|March 10, 2009
The c-MYC-AP4-p21 cascadePeter Jung, Heiko Hermeking
Pageof 12